Adams Brian
Chief Legal Officer
Adams Brian has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Adams Brian is listed as Chief Legal Officer at Kymera Therapeutics, Inc. Inside the rolling window, Adams Brian reported no open-market purchases and 1 open-market sale totaling $744K in KYMR.
Companies traded
Other insiders at KYMR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$744K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Adams Brian made?
Adams Brian has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Adams Brian trade?
Adams Brian has filed SEC Form 4 disclosures for 1 company, including KYMR.
When was Adams Brian's most recent SEC Form 4 filing?
Adams Brian's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Adams Brian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Adams Brian is listed as Chief Legal Officer.
What is Adams Brian's total buy and sell value in the current window?
Inside the rolling retention window, Adams Brian bought $0 and sold $744K based on SEC Form 4 filings.
What was Adams Brian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,371 KYMR shares on 2026-09-04, worth $744K, per SEC Form 4 filings.